Chemistry and pharma Why the AI drug revolution has yet to deliver Speed, safety and smarter molecules have yet to translate into better medicines reaching patients. The real breakthrough may come from rethinking what we ask AI to do in the lab, writes Robert Roe Latest Content UK consortium to help accelerate adoption of low carbon medicinal manufacturing ELRIG Announces Prof Hazel Screen and Dr Dave Powell as Keynote Speakers for Advances in Cell-based Screening 2026 Why the AI drug revolution has yet to deliver New technologies QC Ware launches Promethium for chemical and materials discovery PhoreMost enhances drug discovery process Optibrium appoints Dr Hamed Tabatabaei Ghomi as Head of Research White papers Protecting bioanalytical data integrity from bench to report Discover how Thermo Scientific™ Watson™ LIMS software safeguards data integrity in bioanalytical studies through traceability, compliance, and automation, reducing regulatory risk and enhancing productivity across the entire bioanalytical process. Future-proofing your lab: key considerations for upgrading or switching chromatography data systems This White Paper guides you in determining whether upgrading your existing system is sufficient or if transitioning to a new CDS is the better, future-ready option. Centralising analytical data from mass spectrometry in drug discovery and development Discover how experts from Zoetis, Bayer, LifeMine Therapeutics, Iterion, Targenomix, and the Pistoia Alliance are solving key data challenges for mass spectrometry applications. Webcasts On Demand: Free Online Panel Discussion | LIMS innovation boosts precision and security Free Energy Perturbation: How Computational Chemistry Saves Time In Drug Discovery More content How a methods database increases lab efficiency Creating better treatments with AI Nvidia BioNeMo enables generative AI for drug discovery AI shapes the future of precision medicine The latest software products for QA/QC in 2023 Pocket-sized DNA sequencers track malaria drug resistance in near real-time Pistoia Alliance sets out its strategy to accelerate sustainability and the adoption of AI £225m investment aims to put the UK at the “forefront of the AI revolution” The low-code/no-code revolution and data management Case study: How AstraZeneca is overcoming obstacles to analytical data access Democratising access to medicine with AI Why completely AI-driven drug discovery is needed Pagination Previous page ‹ Previous Page 10 Next page Next ›
